ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing
暂无分享,去创建一个
François-Clément Bidard | Anne Vincent-Salomon | Alexandre Eeckhoutte | Alexandre Houy | Elodie Manié | Manon Reverdy | Ivan Bièche | Elisabetta Marangoni | Oumou Goundiam | Dominique Stoppa-Lyonnet | Marc-Henri Stern | Tatiana Popova | A. Vincent-Salomon | I. Bièche | M. Stern | D. Stoppa-Lyonnet | F. Bidard | E. Marangoni | Elodie Manié | T. Popova | Alexandre Houy | Oumou Goundiam | Alexandre Eeckhoutte | Manon Reverdy | O. Goundiam | A. Eeckhoutte | M. Stern | T. Popova
[1] Z. Szallasi,et al. Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer , 2018, npj Breast Cancer.
[2] Isidro Cortés-Ciriano,et al. Detecting the mutational signature of homologous recombination deficiency in clinical samples , 2019, Nature Genetics.
[3] P. Gestraud,et al. Histo‐genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non‐BRCAness high grade ovarian carcinoma , 2015, International journal of cancer.
[4] David C. Jones,et al. Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.
[5] A. Vincent-Salomon,et al. Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation. , 2012, Cancer research.
[6] L. Saal,et al. Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study , 2019, Nature Medicine.
[7] E. Birney,et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures , 2017, Nature Medicine.
[8] G. Mills,et al. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer , 2012, British Journal of Cancer.
[9] Tom Sante,et al. Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients , 2017, Clinical Cancer Research.
[10] Nikhil Wagle,et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors , 2017, Nature Communications.
[11] E. Lander,et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer , 2017, Nature Genetics.
[12] A. Sethi,et al. The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research. , 2017, Cancer research.
[13] M. Morgan,et al. Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer. , 2019, The New England journal of medicine.
[14] Tatiana Popova,et al. Supplementary Methods , 2012, Acta Neuropsychiatrica.
[15] E. Barillot,et al. Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays , 2009, Genome Biology.
[16] Z. Szallasi,et al. Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. , 2012, Cancer discovery.
[17] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..